Voisard Asset Management Group, Inc. Vertex Pharmaceuticals Inc Transaction History
Voisard Asset Management Group, Inc.
- $240 Billion
- Q3 2024
A detailed history of Voisard Asset Management Group, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Voisard Asset Management Group, Inc. holds 159 shares of VRTX stock, worth $73,411. This represents 0.03% of its overall portfolio holdings.
Number of Shares
159
Previous 281
43.42%
Holding current value
$73,411
Previous $132 Million
43.86%
% of portfolio
0.03%
Previous 0.06%
Shares
4 transactions
Others Institutions Holding VRTX
# of Institutions
1,724Shares Held
222MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$12.4 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$10.7 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.84 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.46 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$4.16 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $119B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...